In cerebral vessels, angiotensin-converting enzyme appears crucial for converting angiotensin I to II, but not for the degradation of bradykinin.
Answers are grounded in this paper and cite their sources.
ACE appears key for AI-to-AII conversion but not BK degradation in cerebral vessels; leaves open relevance to human hypertension.
Bradykinin (BK) produced concentration-related relaxations of cat middle cerebral arteries and was ineffective in cat basilar arteries. On rabbit basilar arteries, BK initially produced concentration-related relaxations; however, when repeated at 2-hour intervals, BK eventually produced pure contractile responses. After preincubation of the tissues with cycloheximide, BK produced reproducible relaxation responses. The angiotensin-converting enzyme inhibitors, SQ 14,225, BPP5a, and BPP9a, had no effect on the concentration-effect curves of BK, AII, or 5-HT with any of the preparations, but responses to AI were inhibited. These results suggest that, in these tissues, angiotensin-converting enzyme is important for conversion of AI to AII, but apparently not for the degradation of BK.
No takes yet. Share an insight, caveat, or question.
Whalley et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: